morn delawar court rule favor freseniu effort termin
merger agreement propos price per share though
share essenti reflect realiti compani stand-alon
entiti read state busi lead us conclud still potenti
downsid put anoth way trade ebitda
context need rebuild manag team resolv myriad observ
associ decatur il facil potenti continu competitive/pr
headwind key product multipl view could contract reiter
neutral rate lower pt reflect believ
fair valu stand-alon entiti
go state limbo quit time
addit key personnel leadership way rank-and-fil
imper matter resolv observ
associ steril inject facil decatur il recal
total observ made follow fda inspect facil batch
inconsist contamin signific number observ ostens
sever defici like put brake approv
facil resolut given backdrop could see rel dearth abbrevi
nda anda approv forese futur seen approv
compar dynam combin potenti
pressur base busi see detail along net
ebitda near view point potenti multipl contract
point refer teva trade ebitda multipl
respect view probabl closest approxim
apples-to-appl compar among major gener compani given
similar term busi mix inject absenc major brand
segment leverag ratio
think ebitda recal number key product
inject ephedrin lidocain ointment experienc major eros due competit
surmis worst like thing
say base busi found trough given could well see
pressur product instanc gener form topic clobetasol
compani second highest sell product sale annual base
sale per iqvia context fairli crowd market
addit price pressur certainli possibl gener form
accutan histor strong product compani may also face pressur given
amneal enter market
risk includ price pressur pressur competit entrant
focus primarili ophthalm inject gener product
price close octob
ep disc
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
pt reflect valu
new pt reflect view stand-alon entiti oppos previou
pt base freseniu offer price new pt base price-to-earnings
ep estim discount two year new pt impli
ebitda view appropri given compani current
capit structur net ebitda near well certain challeng face
busi ad new personnel resolv manufactur issu decatur il facil
face continu headwind associ base gener busi multipl reflect
contract current level point refer current trade
ebitda context similar capit structur fair share headwind
face legaci gener busi though believ endp inject busi far
sound foot compar akrx inject segment
page
 quarterli annual incom statement
million except ep
sale
sell gener administr
amort intang
incom loss tax
expens revenu
cog total revenu
sell gener administr
note report result throughout pjc number exclud estim non-cash one time relat expens stock base compens merger relat cost sg line item
histor may provid segment revenu inform estim actual may base pjc estim im data
exclud stock-bas compens expens acquisit relat cost
reflect adjust impair process
proprietari piper jaffray co august
page
million
net chang asset liabil
acquisit tangibl asset
acquisit intang
stock option issuanc
proprietari piper jaffray co august
page
million
proprietari piper jaffray co august
page
